RPL23AP94

Across TCGA pan-cancer cohorts, RPL23AP94 RNA is linked to patient survival in 13 of 34 cancer types, making it the most broadly survival-associated RPL23AP94 data layer.

The strongest signal is observed in thymoma (THYM), where higher RPL23AP94 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RPL23AP94 expression acts as an unfavorable survival marker, although some lineages such as READ and GBM show a favorable association.

THYM, ACC, and PCPG are the cancer types where RPL23AP94 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
THYM	OS	Tertile	All	0.779	0.979	<.001	96	view →
ACC	DFS	Tertile	All	0.173	0.611	.003	54	view →
PCPG	OS	Tertile	All	0.322	0.982	.001	36	view →
LUAD	DFS	Tertile	II,III,IV	0.379	0.731	.001	36	view →
ESCA	OS	Tertile	All	0.402	0.947	<.001	36	view →
CESC	OS	Tertile	IV	0.091	0.593	<.001	36	view →
PAAD	OS	Tertile	II,III,IV	0.303	0.563	.006	21	view →
UVM	OS	Tertile	All	0.248	0.769	.007	18	view →
KIRC	DFS	Tertile	IV	0.217	0.603	.013	18	view →
READ	DFS	Tertile	II,III,IV	0.822	0.329	.014	18	view →
GBM	OS	Tertile	All	0.439	0.236	.010	15	view →
OV	OS	Tertile	IV	0.912	0.563	.021	12	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 13 lineages.

RPL23AP94–THYM (OS)

Open the THYM breakdown →